Indivior to Resolve U.S. Opioid Treatment Marketing Claims For $600 Million
Indivior Plc on Friday said it had agreed to pay $600 million and have a subsidiary plead guilty to a criminal charge to resolve U.S. allegations that it engaged in an illegal scheme to boost prescriptions of its opioid addiction …